IP Library Granted Patent US 7,381,796
Granted Patent B2
US 7,381,796 · App. 11/690,778 · Granted Jun 3, 2008

Dried blood factor composition comprising trehalose

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,381,796
App. No.
11/690,778
Granted
Jun 3, 2008
Kind
B2
Abstract

A method for preparing a stable dried composition of blood factor product containing a stabilizing amount of trehalose in the absence of a stabilizing amount of albumin is disclosed.

Claims (8)

1. A method for preparing vial containing a dry composition, said composition comprising recombinant native Factor VIII, a Factor VIII-stabilizing amount of trehalose, and no albumin, the composition being

(a) stable without refrigeration, and

(b) suitable for reconstitution with water or with an aqueous solution for administration to a hemophilic patient,

which method comprises placing an albumin-free aqueous solution comprising recombinant native Factor VIII and trehalose in a vial and freeze-drying the solution.

2. The method of claim 1 , wherein the dry composition contains 0.15 to 2.5 mg trehalose per unit of recombinant native Factor VIII.

3. The method of claim 1 , wherein the dry composition further comprises NaCl and the molar ratio of trehalose to NaCl is above 1:1.

4. The method of claim 3 , wherein the molar ratio of trehalose to NaCl is above 2.5:1.

5. The method of claim 4 , wherein the molar ratio of trehalose to NaCl is more than 10:1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2007
From: QUADRANT HEALTHCARE (UK) LIMITED
To: ELAN DRUG DELIVERY LIMITED
Reel/Frame 019734/0204 →
CHANGE OF NAME Recorded Aug 22, 2007
From: ELAN DRUG DELIVERY LIMITED
To: QUADRANT DRUG DELIVERY LIMITED
Reel/Frame 019734/0413 →